These companies are illegally selling products claiming to treat Alzheimer’s

This post was originally published on this site

The U.S. Food and Drug Administration has taken action against 17 companies illegally selling more than 58 products, many as dietary supplements, that claim to treat Alzheimer’s disease and other serious diseases and health conditions.

The 12 warning letters and 5 online advisory letters said the products are “unapproved new drugs and/or misbranded drugs” that have been sold in violation of the Federal Food, Drug and Cosmetic Act, as they claim to prevent, treat or cure Alzheimer’s and other diseases. The products include those sold as tablets, capsules and oils.

“These products, which are often sold on websites and social media platforms, have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat,” the FDA said in a statement. “These products may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment.”

The companies warned have been asked to respond to the FDA within days, stating how the violations will be corrected. Failure to correct the violations promptly may result in legal action, the FDA said.

The actions are part of the FDA’s efforts to address the growth of the dietary supplement industry, which has grown to a $40 billion industry, with anywhere between 50,000 and 80,000 or more products, from a $4 billion industry with 4,000 products, in the 25 years since Congress passed the Dietary Supplement Health and Education Act (DSHEA).

Three out of four Americans take a daily dietary supplement, including one in three children and teens and four of five older Americans.

“Science and evidence are the cornerstone of the FDA’s review process and are imperative to demonstrating medical benefit, especially when a product is marketed to treat serious and complex diseases like Alzheimer’s,” FDA Commissioner Scott Gottlieb said. “Simply put, health fraud scams prey on vulnerable populations, waste money and often delay proper medical care – and we will continue to take action to protect patients and caregivers from misleading, unproven products.”

Meanwhile, the FDA did not address CBD, or non-psychoactive cannabinoid, that some companies have claimed to have medicinal qualities, including as a treatment for Alzheimer’s. Many of the claims were made after the 2018 farm bill was signed by President Donald Trump, which legalized hemp but kept CBD illegal without FDA approval.

Don’t miss: Hemp is now legal in the U.S., so what does that mean for pot companies?

See also: Everything you need to know about CBD, the non-intoxicating cannabis elixir that isn’t fully legal—yet.

“We welcome the need to look ahead but FDA cannot ignore today’s challenges in the meantime: Their inaction on one of the hottest products, CBDs, is a case in point,” said the Natural Products Association in a statement.

The ETFMG Alternative Harvest exchange-traded fund MJ, -1.67% has rallied 4.3% over the past three months and the Horizons Marijuana Life Sciences Index ETF HMMJ, -2.11% has gained 1.2%, while the S&P 500 index SPX, +0.05% has slipped 2.6%.

Here are the 17 companies that received warnings:

Company Products named by FDA Warning (subject)
Blue Ridge Silver BLUE RIDGE SILVER Colloidal Silver Warning letter (new drug/labeling/misbranded)
Capri Associates Inc./BR Naturals Avocado Oil, Black Seed Oil, Moringa Power, Premium Olive Oil D.O.P, Pumpkin Seed Oil, Unrefined Coconut Oil Warning letter (new drug/labeling/misbranded)
DK Vitamins Ubiquinol CoQ10, Cognispark, Vinpurazine, Melatonin Gammadyn Mn-Co, Zinc Picolinate Formula Warning letter (new drug/labeling/misbranded)
Earth Turns LLC Green Tea Extract, Cogni-Flex, GlucoFit 48mg, Fundamental D3 1000, Fundamental Omega-3 Warning letter (new drug/labeling/misbranded)
Emmbros Overseas Lifestyle PVT Ltd. Morpheme Remedies Arthcare Plus, Morpheme Remedies Cinnamon, Morpheme Remedies Diabeta Plus, Daily Vital Multivitamin, Morpheme Remedies Fenugreek, Morpheme Remedies Garlic, Morpheme Remedies Guduchi, Morpheme Remedies Memocare Plus, Morpheme Remedies Mind Plus, Morpheme Remedies Mucuna Pruriens, Nourish Vitals Seed & Fruit Mix, St. Botanic Fish Oil Warning letter (new drug/labeling/misbranded)
Gold Crown Natural Products New Ultra Colostrum, Melatonin with Valerian, Anamu & Llanten, Circulation Max Warning letter (new drug/labeling/misbranded)
John Gray’s Mars Venus LLC 2-AEP Membrane Complex, Ionic Silver Water, L-Glutathione, Liposomal DHA–Ultimate Omega-3 Brain Support, Liposomal Methyl B12/Folate, NAC N-Acetyl-L-Cysteine, Vectomega Warning letter (new drug/labeling/misbranded)
Nutrition Coalition Inc. Alpha-Lipoic Acid, Colostrum Alpha Whey III (Liquid), Colloidal Silver, CoQ10, Curcumin, Echinacea Root, Liva-Vite, L-Carnitine, Milk Thistle, Selenium, Ultimate Willard’s Water Lotion with Goat’s Milk, Vinpocetine, Vitamin B Complex, Vitamin C, Vitamin D3, Vitamin E, Willard’s Water Warning letter (new drug/labeling/misbranded)
Peak Nootropics LLC (aka Advanced Nootripics) Adrafinil, Aniracetam, Bacopa Monnieri, L-Dopa, L-Theanine, Noopept, Oxiracetam, Phenibut, Phenylpiracetam, Piracetam, Rhodiola Rosea, Uridine Warning letter (new drug/labeling/misbranded)
Pure Nootropics LLC Alpha GPC, Lion’s Mane, CDP Choline Capsules, Piracetam, Vitamin D3 5000 IU, Turkey Tail Mushroom Powder, Ginkgo Biloba Capsules Warning letter (new drug/labeling/misbranded)
Sovereign Laboratories LLC Colostrum-LD, Viralox, Curcumin-LD Warning letter (new drug/labeling/misbranded)
TEK Naturals BURN4Her, BurnerTEK, Mind Ignite, TEK Male, TestoTEK Warning letter (new drug/labeling/misbranded)
Alzheimer’s Corp. Memory Revitalizer, Cerebara GPC, and Life Imagined Online advisory letter
Alzheimer’s Organization Mind and Memory Support Online advisory letter
Dr. Fitt Intelligent Designs LLC BALI Greens, BALI Purples, Black Seed Oil, DHEA Capsules, Lugol’s Solution 2% Drops, Robenyzme Capsules, OMG Max Drops, New Dawn Capsules, Vitamin C with R-Lipoic Acid Online advisory letter
Healthcare Products LLC (d/b/a The Alzheimer’s Store d/b/a MindCare Store) Aromatherapy for Dementia Memory Kit Premier Edition, Aromatherapy for Dementia Memory Kit Second Edition, Bodyguard Blend Essential Oil, ClearMind Blend Essential Oil, Lavender Essential Oil, Attention Aromatherapy Patch, Calming Aromatherapy Patch, Lavender Aromatherapy Patch, Perk Up Aromatherapy Patch, Refresh Aromatherapy Patch, Rested Aromatherapy Patch, Aromatherapy Patch Sample Pack Online advisory letter
This Wonderful Life New Age Shop Dementia/Alzheimer’s (Day) Synergy Oil, Dementia/Alzheimer’s (Night) Synergy Oil, Joints/Arthritis/Rheumatism Massage Oil 50ml, Angelica Root 10% (in Coconut), Melissa 10% (in Coconut) Essential Oil 10ml, Cajeput Essential Oil, Juniperberry Essential Oil, Black Pepper Essential Oil, Nutmeg Essential Oil, Palo Santo (Ecuador) Essential Oil, Palo Santo (Peru) Essential Oil, Cinnamon Leaf Essential Oil, Vetiver Essential Oil, Yarrow Essential Oil, Sweet Thyme Essential Oil, Pine Scotch Essential Oil, Myrrh Essential Oil, May Chang Essential Oil, Manuka 10% (in Coconut) Essential Oil, Jasmine Absolute 10% (in Coconut) Essential Oil, Galbanum Essential Oil 10% (in Coconut) Essential Oil, Bergamot Essential Oil, Camphor Essential Oil Online advisory letter
U.S. Food and Drug Administration
Be Sociable, Share!

Related Posts


MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.